NEW YORK (GenomeWeb) – Transgenomic today announced its shareholders have approved the previously announced planed merger with Precipio Diagnostics.

More than 90 percent of votes cast by Transgenomic's shareholders gave the go-ahead to the deal at a special shareholders meeting held on Monday, the firm said. Additionally, more than 95 percent of Precipio's voting members approved the merger.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.